feed,title,long_url,short_url
MedRxiv,"Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru",https://medrxiv.org/cgi/content/short/2022.05.01.22274548v1?rss=1,https://bit.ly/3KHTp7A
